{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:08:30Z","timestamp":1788052110238,"version":"build-2784847793"},"reference-count":60,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202466048","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T13:12:59Z","timestamp":1724677979000},"source":"Crossref","is-referenced-by-count":6,"title":["Novel approaches for HTLV-1 therapy: innovative applications of CRISPR-Cas9"],"prefix":"10.1590","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-8181","authenticated-orcid":false,"given":"Wilson","family":"Domingues","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0114-7587","authenticated-orcid":false,"given":"Victor \u00c2ngelo","family":"Folgosi","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8876-8262","authenticated-orcid":false,"given":"Sabri Saeed","family":"Sanabani","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-0487","authenticated-orcid":false,"given":"Pedro Domingos","family":"Leite Junior","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0993-4523","authenticated-orcid":false,"given":"Tatiane","family":"Assone","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4553-2559","authenticated-orcid":false,"given":"Jorge","family":"Casseb","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain A","year":"2012","journal-title":"Front Microbiol"},{"key":"ref2","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"1","author":"Bangham CR","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107669","article-title":"An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) focusing on clinical and laboratory biomarkers","volume":"218","author":"Yamauchi J","year":"2021","journal-title":"Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.25072","article-title":"Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM\/TSP) and multiple sclerosis (MS)","volume":"82","author":"Azodi S","year":"2017","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0272989X15613521","article-title":"Brazilian valuation of EQ-5D-3L health states: results from a saturation study","volume":"36","author":"Santos M","year":"2016","journal-title":"Med Decis Making"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006967","article-title":"Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: association with high proviral load","volume":"13","author":"Haziot ME","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood-2011-03-345702","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"118","author":"Bazarbachi A","year":"2011","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama M","year":"1991","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41375-021-01253-x","article-title":"T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments","volume":"35","author":"Daver N","year":"2021","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.3390\/v14010136","article-title":"Efficacy of corticosteroid therapy for HTLV-1-associated myelopathy: a randomized controlled trial (HAMLET-P)","volume":"14","author":"Yamauchi J","year":"2022","journal-title":"Viruses"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-019-0484-z","article-title":"Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL","volume":"16","author":"Kannagi M","year":"2019","journal-title":"Retrovirology"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2230015","article-title":"Identification of miRnas with possible prognostic roles for HAM\/TSP","volume":"14","author":"Souza DR","year":"2023","journal-title":"Virulence"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virusres.2017.01.016","article-title":"HTLV-1 Tax impairs K63-linked ubiquitination of STING to evade host innate immunity","volume":"232","author":"Wang J","year":"2017","journal-title":"Virus Res"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073600","article-title":"Natterin-induced neutrophilia is dependent on cGAS\/STING activation via type I IFN signaling pathway","volume":"23","author":"Lima C","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref15","article-title":"The cGAS-STING pathway in viral infections: a promising link between inflammation, oxidative stress and autophagy","volume":"15","author":"Zhang K","year":"2024","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.cellsig.2010.06.004","article-title":"Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation","volume":"22","author":"Kim JE","year":"2010","journal-title":"Cell Signal"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00285","article-title":"HTLV deregulation of the NF-kappaB pathway: an update on tax and antisense proteins role","volume":"9","author":"Fochi S","year":"2018","journal-title":"Front Microbiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"12813","DOI":"10.1128\/JVI.76.24.12813-12822.2002","article-title":"The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription","volume":"76","author":"Gaudray G","year":"2002","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.580371","article-title":"CRISPR genome editing applied to the pathogenic retrovirus HTLV-1","volume":"10","author":"Panfil AR","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2012.00247","article-title":"HBZ and its roles in HTLV-1 oncogenesis","volume":"3","author":"Zhao T","year":"2012","journal-title":"Front Microbiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-5793(04)00225-X","article-title":"HBZ interacts with JunD and stimulates its transcriptional activity","volume":"562","author":"Th\u00e9bault S","year":"2004","journal-title":"FEBS Lett"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-6-71","article-title":"The HBZ gene, a key player in HTLV-1 pathogenesis","volume":"6","author":"Matsuoka M","year":"2009","journal-title":"Retrovirology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrg2749","article-title":"CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea","volume":"11","author":"Marraffini LA","year":"2010","journal-title":"Nat Rev Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin","volume":"151","author":"Bolotin A","year":"2005","journal-title":"Microbiology (Reading)"},{"key":"ref25","article-title":"Control of plant viral diseases by CRISPR\/Cas9: resistance mechanisms, strategies and challenges in food crops","volume":"10","author":"Shahriar SA","year":"2021","journal-title":"Plants (Basel)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek M","year":"2012","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910355","article-title":"Comparison of the feasibility, efficiency, and safety of genome editing technologies","volume":"22","author":"Gonzalez Castro N","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42223-4","article-title":"Digital data storage on DNA tape using CRISPR base editors","volume":"14","author":"Sadremomtaz A","year":"2023","journal-title":"Nat Commun"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0496","article-title":"CRISPR-Cas: biology, mechanisms and relevance","volume":"371","author":"Hille F","year":"2016","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-018-0255-x","article-title":"Class 2 CRISPR\/Cas: an expanding biotechnology toolbox for and beyond genome editing","volume":"8","author":"Tang Y","year":"2018","journal-title":"Cell Biosci"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111321","article-title":"Editing SOX genes by CRISPR-Cas: current insights and future perspectives","volume":"22","author":"Dehshahri A","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref32","first-page":"353","article-title":"Mechanism and applications of CRISPR\/Cas-9-mediated genome editing","volume":"15","author":"Asmamaw M","year":"2021","journal-title":"Biologics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Chang HH","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-022-00483-y","article-title":"CRISPR\/Cas9: a tool to eradicate HIV-1","volume":"19","author":"Bhowmik R","year":"2022","journal-title":"AIDS Res Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1128\/JVI.73.6.4856-4865.1999","article-title":"Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone","volume":"73","author":"Robek MD","year":"1999","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1128\/JVI.74.6.2655-2662.2000","article-title":"Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFkappaB or CREB\/ATF activation fail to transform primary human T cells","volume":"74","author":"Ross TM","year":"2000","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"23903","DOI":"10.1074\/jbc.M803116200","article-title":"An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300\/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ","volume":"283","author":"Clerc I","year":"2008","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.957535","article-title":"Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia","volume":"13","author":"El Hajj H","year":"2022","journal-title":"Front Immunol"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914807","article-title":"Human T-cell leukemia virus type 1 oncogenesis between active expression and latency: a possible source for the development of therapeutic targets","volume":"24","author":"Marino-Merlo F","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","article-title":"Multiple viral strategies of HTLV-1 for dysregulation of cell growth control","volume":"19","author":"Yoshida M","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1159\/000486168","article-title":"Oncogenic human papillomavirus: application of CRISPR\/Cas9 therapeutic strategies for cervical cancer","volume":"44","author":"Zhen S","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"ref42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166601","article-title":"A frequent PLCgamma1 mutation in adult T-cell leukemia\/lymphoma determines functional properties of the malignant cells","volume":"1869","author":"Prawiro C","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008879","article-title":"Transfer of HTLV-1 p8 and Gag to target T-cells depends on VASP, a novel interaction partner of p8","volume":"16","author":"Donhauser N","year":"2020","journal-title":"PLoS Pathog"},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.14741.2","article-title":"Epigenetic changes around the pX region and spontaneous HTLV-1 transcription are CTCF-independent","volume":"3","author":"Miura M","year":"2018","journal-title":"Wellcome Open Res"},{"key":"ref45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008504","article-title":"The E3\/E4 ubiquitin conjugation factor UBE4B interacts with and ubiquitinates the HTLV-1 Tax oncoprotein to promote NF-kappaB activation","volume":"16","author":"Mohanty S","year":"2020","journal-title":"PLoS Pathog"},{"key":"ref46","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01302","article-title":"TRAF3 is required for NF-kappaB pathway activation mediated by HTLV tax proteins","volume":"10","author":"Fochi S","year":"2019","journal-title":"Front Microbiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2016.09.006","article-title":"Determining antigen specificity of a monoclonal antibody using genome-scale CRISPR-Cas9 knockout library","volume":"439","author":"Zotova A","year":"2016","journal-title":"J Immunol Methods"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/v3071074","article-title":"HTLV-3\/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects","volume":"3","author":"Mahieux R","year":"2011","journal-title":"Viruses"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00950-17","article-title":"Simian T lymphotropic virus 1 infection of Papio anubis: tax sequence heterogeneity and T cell recognition","volume":"91","author":"Termini JM","year":"2017","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-019-0503-0","article-title":"STLV-1 as a model for studying HTLV-1 infection","volume":"16","author":"J\u00e9gado B","year":"2019","journal-title":"Retrovirology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0036-46652015000100001","article-title":"Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas","volume":"57","author":"Paiva A","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref52","first-page":"909","article-title":"Implications of the evolution pattern of human T-cell leukemia retroviruses on their pathogenic virulence (review)","volume":"14","author":"Azran I","year":"2004","journal-title":"Int J Mol Med"},{"key":"ref53","article-title":"CRISPR\/Cas systems in genome editing: methodologies and tools for sgRNA design, off-target evaluation, and strategies to mitigate off-target effects","volume":"7","author":"Manghwar H","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1172\/JCI72992","article-title":"Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9","volume":"124","author":"Gupta RM","year":"2014","journal-title":"J Clin Invest"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/nar\/gkx1199","article-title":"Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs","volume":"46","author":"Ryan DE","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"ref56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA base-editing and prime-editing","volume":"21","author":"Kantor A","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref57","first-page":"259","article-title":"In vitro pre-validation of gene editing by CRISPR\/Cas9 ribonucleoprotein","volume":"11","author":"Mehravar M","year":"2019","journal-title":"Avicenna J Med Biotechnol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai SQ","year":"2015","journal-title":"Nat Biotechnol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"CRISPR\/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery","volume":"117","author":"Wang HX","year":"2017","journal-title":"Chem Rev"},{"key":"ref60","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.673286","article-title":"Nanoparticle delivery of CRISPR\/Cas9 for genome editing","volume":"12","author":"Duan L","year":"2021","journal-title":"Front Genet"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652024000100402&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T13:13:41Z","timestamp":1724678021000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652024000100402&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":60,"alternative-id":["S0036-46652024000100402"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202466048","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e48"}}